CII protein

Last updated
Transcriptional activator II
CII DNA.png
Crystal structure of λcII-DNA complex [1]
Identifiers
Organism Escherichia virus Lambda
SymbolcII
Entrez 2703494
PDB 1ZPQ
RefSeq (Prot) NP_040630.1
UniProt P03042
Other data
Chromosome genomic: 0.04 - 0.04 Mb
Search for
Structures Swiss-model
Domains InterPro

cII or transcriptional activator II is a DNA-binding protein and important transcription factor in the life cycle of lambda phage. [1] It is encoded in the lambda phage genome by the 291 base pair cII gene. [2] cII plays a key role in determining whether the bacteriophage will incorporate its genome into its host and lie dormant (lysogeny), or replicate and kill the host (lysis). [3]

Contents

Introduction

cII is the central “switchman” in the lambda phage bistable genetic switch, allowing environmental and cellular conditions to factor into the decision to lysogenize or to lyse its host. [4] cII acts as a transcriptional activator of three promoters on the phage genome: pI, pRE, and pAQ. [3] cII is an unstable protein with a half-life as short as 1.5 mins at 37˚C, [5] enabling rapid fluctuations in its concentration. First isolated in 1982, [6] cII's function in lambda's regulatory network has been extensively studied.

Structure and properties

Helix-turn-helix DNA binding domains (pink) in tetramerized cII protein HTH.png
Helix-turn-helix DNA binding domains (pink) in tetramerized cII protein

cII binds DNA as a tetramer, composed of identical 11 kDa subunits. [7] Although the cII gene encodes 97 codons, the mature cII protein subunit only contains 95 amino acids due to post-translational cleavage of the first two amino acids (fMet and Val). [6] cII is toxic to bacteria when overexpressed, as it inhibits DNA synthesis. [8]

cII binds to a homologous region 35 base pairs upstream of the promoters pI, pRE and pAQ. [7] Unlike other DNA binding proteins, cII recognizes a direct repeat sequence TTGCN6TTGC rather than sequences that form palindromes. [7] cII binds DNA ~2 orders of magnitude less strongly than the lambda repressor cI [7] (3), and has a dissociation constant of ~80nM. [2] DNA binding is achieved using the common helix-turn-helix motif [1] (15), located between residues 26 and 45. [7] On either side of the DNA-binding domain are domains crucial for tetramer formation, located in residues 9-25 and 46–71. [7] cII's inherent in vivo instability stems from a C-terminal degradation tag, consisting of residues 89–97. This tag is recognized by host proteases HflA and HflB, cause rapid proteolysis cII. [9] Although the C-terminal tag is still accessible when cII is tetramerized [2] (13), the rate of proteolytic degradation decreases, since Hfl proteases only degrade cII monomers. [9]

Function

cII's primary role in the lambda phage regulatory network is to initiate the repressor establishment cascade. Once lysogeny is established, cII is no longer needed, and thus is turned off. It serves as the switch element for establishing repression of the lytic genes after infection, producing the lysogenic phenotype. [3]

cII is first expressed after phage protein N reaches sufficient levels to antiterminate the early right transcript past tR1, allowing RNA polymerase to transcribe the cII gene. [10] If cII levels reach a certain threshold level, expression through the promoters pI, pRE and pAQ will be induced, initiating the two actions necessary in establishing lysogeny: 1) repression of lytic genes and 2) integration of the phage genome into the host's chromosome. [11] Activation of promoter pRE enables expression of the repressor protein cI, which shuts off all lytic genes. pRE activation is also accompanied with a ~2 fold drop in pR activity due to convergent transcription of the two promoters, decreasing the expression of the lytic genes O and P. [12] Activation of promoter pAQ produces the antisense RNA for Q, a key protein in the activation of the late lytic genes. Production of antisense Q RNA shuts off Q production, reducing lytic activity until the repressor cI can adequately shut off all lytic gene expression. [13] Activation of the promoter pI causes the expression of the phage protein Int, whose role is to integrate the phage genome into the host's chromosome. [3] Thus, although cII levels play a large role in determining the cell's fate, random thermal fluctuations also partially determine whether lysis or lysogeny is chosen. [4]

Lambda phage regulatory network: expression of cII Genetic circuit.png
Lambda phage regulatory network: expression of cII

The level of cII in the cell during infection is highly variable due to its inherent in vivo instability, and its levels are highly influenced by environmental and cellular factors that influence its degradation rate. [4] Such factors include temperature, [14] cellular starvation and number of phage infecting the cell (an indication of population number of phage). [4] Experiments have shown that low temperatures increase the in vivo half-life of cII from ~1-2 mins at 37˚C to 20 mins at 20˚C, thus increasing the probability of a cell to lysogenize. It is postulated that cII's increased stability at lower temperatures may be due to increased tetramerization and/or decreased Hfl-protease activity. [14] Similarly, because host Hfl-proteases degrade proteins in an ATP dependent manner, coupling cII levels to Hfl-protease activity allows the bacteriophage to sense the energy status of the cell (healthy or starved). [15] Thus lysogeny is favored when cells are starved. [14] Finally, if a bacterial cell is infected by multiple bacteriophages, the level of cII increases due to additional contributions from each infecting phage. Lysogeny is therefore also favored in cells infected by multiple phages. [4]

Regulation

cII levels during infection exhibit extensive post-transcriptional regulation.

  1. Translation
    • translation of the cII gene within the early right transcript depends on N antitermination
  2. cII mRNA degradation:
    • The mRNA coding for the C-terminal end of cII overlaps with OOP RNA (a 77 base pair antisense RNA originating downstream of cII) by 16 codons.
    • OOP hybridizes to cII mRNA, forming double stranded RNA.
    • The double stranded OOP-cII RNA complex is susceptible to host RNAse III hydrolysis, destroying the cII RNA. [16]
  3. Host protease dependent degradation:
    • C-terminal degradation tag is recognized by host HflA and HflB proteases, quickly degrading any cII they encounter.
  4. Tetramerization:
    • oligomerization to the tetramer increases cII's stability, allowing cII levels to accumulate at a greater rate. [9]

Related Research Articles

<span class="mw-page-title-main">Bacteriophage</span> Virus that infects and replicates within bacteria

A bacteriophage, also known informally as a phage, is a virus that infects and replicates within bacteria and archaea. The term was derived from "bacteria" and the Greek φαγεῖν, meaning "to devour". Bacteriophages are composed of proteins that encapsulate a DNA or RNA genome, and may have structures that are either simple or elaborate. Their genomes may encode as few as four genes and as many as hundreds of genes. Phages replicate within the bacterium following the injection of their genome into its cytoplasm.

<span class="mw-page-title-main">Lambda phage</span> Bacteriophage that infects Escherichia coli

Enterobacteria phage λ is a bacterial virus, or bacteriophage, that infects the bacterial species Escherichia coli. It was discovered by Esther Lederberg in 1950. The wild type of this virus has a temperate life cycle that allows it to either reside within the genome of its host through lysogeny or enter into a lytic phase, during which it kills and lyses the cell to produce offspring. Lambda strains, mutated at specific sites, are unable to lysogenize cells; instead, they grow and enter the lytic cycle after superinfecting an already lysogenized cell.

In genetics, an operon is a functioning unit of DNA containing a cluster of genes under the control of a single promoter. The genes are transcribed together into an mRNA strand and either translated together in the cytoplasm, or undergo splicing to create monocistronic mRNAs that are translated separately, i.e. several strands of mRNA that each encode a single gene product. The result of this is that the genes contained in the operon are either expressed together or not at all. Several genes must be co-transcribed to define an operon.

<span class="mw-page-title-main">Cloning vector</span> Small piece of maintainable DNA

A cloning vector is a small piece of DNA that can be stably maintained in an organism, and into which a foreign DNA fragment can be inserted for cloning purposes. The cloning vector may be DNA taken from a virus, the cell of a higher organism, or it may be the plasmid of a bacterium. The vector contains features that allow for the convenient insertion of a DNA fragment into the vector or its removal from the vector, for example through the presence of restriction sites. The vector and the foreign DNA may be treated with a restriction enzyme that cuts the DNA, and DNA fragments thus generated contain either blunt ends or overhangs known as sticky ends, and vector DNA and foreign DNA with compatible ends can then be joined by molecular ligation. After a DNA fragment has been cloned into a cloning vector, it may be further subcloned into another vector designed for more specific use.

<span class="mw-page-title-main">Prophage</span> Bacteriophage genome that is integrated into a bacterial cell

A prophage is a bacteriophage genome that is integrated into the circular bacterial chromosome or exists as an extrachromosomal plasmid within the bacterial cell. Integration of prophages into the bacterial host is the characteristic step of the lysogenic cycle of temperate phages. Prophages remain latent in the genome through multiple cell divisions until activation by an external factor, such as UV light, leading to production of new phage particles that will lyse the cell and spread. As ubiquitous mobile genetic elements, prophages play important roles in bacterial genetics and evolution, such as in the acquisition of virulence factors.

<span class="mw-page-title-main">Transduction (genetics)</span> Transfer process in genetics

Transduction is the process by which foreign DNA is introduced into a cell by a virus or viral vector. An example is the viral transfer of DNA from one bacterium to another and hence an example of horizontal gene transfer. Transduction does not require physical contact between the cell donating the DNA and the cell receiving the DNA, and it is DNase resistant. Transduction is a common tool used by molecular biologists to stably introduce a foreign gene into a host cell's genome.

<span class="mw-page-title-main">Lytic cycle</span> Cycle of viral reproduction

The lytic cycle is one of the two cycles of viral reproduction, the other being the lysogenic cycle. The lytic cycle results in the destruction of the infected cell and its membrane. Bacteriophages that only use the lytic cycle are called virulent phages.

A phagemid or phasmid is a DNA-based cloning vector, which has both bacteriophage and plasmid properties. These vectors carry, in addition to the origin of plasmid replication, an origin of replication derived from bacteriophage. Unlike commonly used plasmids, phagemid vectors differ by having the ability to be packaged into the capsid of a bacteriophage, due to their having a genetic sequence that signals for packaging. Phagemids are used in a variety of biotechnology applications; for example, they can be used in a molecular biology technique called "Phage Display".

<span class="mw-page-title-main">Antisense RNA</span>

Antisense RNA (asRNA), also referred to as antisense transcript, natural antisense transcript (NAT) or antisense oligonucleotide, is a single stranded RNA that is complementary to a protein coding messenger RNA (mRNA) with which it hybridizes, and thereby blocks its translation into protein. The asRNAs have been found in both prokaryotes and eukaryotes, and can be classified into short and long non-coding RNAs (ncRNAs). The primary function of asRNA is regulating gene expression. asRNAs may also be produced synthetically and have found wide spread use as research tools for gene knockdown. They may also have therapeutic applications.

<span class="mw-page-title-main">Lysogenic cycle</span> Process of virus reproduction

Lysogeny, or the lysogenic cycle, is one of two cycles of viral reproduction. Lysogeny is characterized by integration of the bacteriophage nucleic acid into the host bacterium's genome or formation of a circular replicon in the bacterial cytoplasm. In this condition the bacterium continues to live and reproduce normally, while the bacteriophage lies in a dormant state in the host cell. The genetic material of the bacteriophage, called a prophage, can be transmitted to daughter cells at each subsequent cell division, and later events can release it, causing proliferation of new phages via the lytic cycle.

HHV Latency Associated Transcript is a length of RNA which accumulates in cells hosting long-term, or latent, Human Herpes Virus (HHV) infections. The LAT RNA is produced by genetic transcription from a certain region of the viral DNA. LAT regulates the viral genome and interferes with the normal activities of the infected host cell.

<span class="mw-page-title-main">T7 phage</span> Species of virus

Bacteriophage T7 is a bacteriophage, a virus that infects bacteria. It infects most strains of Escherichia coli and relies on these hosts to propagate. Bacteriophage T7 has a lytic life cycle, meaning that it destroys the cell it infects. It also possesses several properties that make it an ideal phage for experimentation: its purification and concentration have produced consistent values in chemical analyses; it can be rendered noninfectious by exposure to UV light; and it can be used in phage display to clone RNA binding proteins.

Antitermination is the prokaryotic cell's aid to fix premature termination of RNA synthesis during the transcription of RNA. It occurs when the RNA polymerase ignores the termination signal and continues elongating its transcript until a second signal is reached. Antitermination provides a mechanism whereby one or more genes at the end of an operon can be switched either on or off, depending on the polymerase either recognizing or not recognizing the termination signal.

P1 is a temperate bacteriophage that infects Escherichia coli and some other bacteria. When undergoing a lysogenic cycle the phage genome exists as a plasmid in the bacterium unlike other phages that integrate into the host DNA. P1 has an icosahedral head containing the DNA attached to a contractile tail with six tail fibers. The P1 phage has gained research interest because it can be used to transfer DNA from one bacterial cell to another in a process known as transduction. As it replicates during its lytic cycle it captures fragments of the host chromosome. If the resulting viral particles are used to infect a different host the captured DNA fragments can be integrated into the new host's genome. This method of in vivo genetic engineering was widely used for many years and is still used today, though to a lesser extent. P1 can also be used to create the P1-derived artificial chromosome cloning vector which can carry relatively large fragments of DNA. P1 encodes a site-specific recombinase, Cre, that is widely used to carry out cell-specific or time-specific DNA recombination by flanking the target DNA with loxP sites.

fis E. coli gene

fis is an E. coli gene encoding the Fis protein. The regulation of this gene is more complex than most other genes in the E. coli genome, as Fis is an important protein which regulates expression of other genes. It is supposed that fis is regulated by H-NS, IHF and CRP. It also regulates its own expression (autoregulation). Fis is one of the most abundant DNA binding proteins in Escherichia coli under nutrient-rich growth conditions.

<span class="mw-page-title-main">Guanosine pentaphosphate</span> Chemical compound

(p)ppGpp, guanosine pentaphosphate and tetraphosphate, also known as the "magic spot" nucleotides, are alarmones involved in the stringent response in bacteria that cause the inhibition of RNA synthesis when there is a shortage of amino acids. This inhibition by (p)ppGpp decreases translation in the cell, conserving amino acids present. Furthermore, ppGpp and pppGpp cause the up-regulation of many other genes involved in stress response such as the genes for amino acid uptake and biosynthesis.

<span class="mw-page-title-main">Bacteriophage P2</span> Species of virus

Bacteriophage P2, scientific name Escherichia virus P2, is a temperate phage that infects E. coli. It is a tailed virus with a contractile sheath and is thus classified in the genus Peduovirus, subfamily Peduovirinae, family Myoviridae within order Caudovirales. This genus of viruses includes many P2-like phages as well as the satellite phage P4.

<span class="mw-page-title-main">RNA thermometer</span> Temperature-dependent RNA structure

An RNA thermometer is a temperature-sensitive non-coding RNA molecule which regulates gene expression. RNA thermometers often regulate genes required during either a heat shock or cold shock response, but have been implicated in other regulatory roles such as in pathogenicity and starvation.

Arbitrium is a viral peptide produced by bacteriophages to communicate with each other and decide host cell fate. It is six amino acids(aa) long, and so is also referred to as a hexapeptide. It is produced when a phage infects a bacterial host. and signals to other phages that the host has been infected.

Phage-assisted continuous evolution (PACE) is a phage-based technique for the automated directed evolution of proteins. It relies on relating the desired activity of a target protein with the fitness of an infectious bacteriophage which carries the protein's corresponding gene. Proteins with greater desired activity hence confer greater infectivity to their carrier phage. More infectious phage propagate more effectively, selecting for advantageous mutations. Genetic variation is generated using error-prone polymerases on the phage vectors, and over time the protein accumulates beneficial mutations. This technique is notable for performing hundreds of rounds of selection with minimal human intervention.

References

  1. 1 2 3 4 Jain D, Kim Y, Maxwell KL, Beasley S, Zhang R, Gussin GN, Edwards AM, Darst SA (July 2005). "Crystal structure of bacteriophage lambda cII and its DNA complex". Molecular Cell. 19 (2): 259–69. doi: 10.1016/j.molcel.2005.06.006 . PMID   16039594.
  2. 1 2 3 Datta AB, Roy S, Parrack P (January 2005). "Role of C-terminal residues in oligomerization and stability of lambda CII: implications for lysis-lysogeny decision of the phage". Journal of Molecular Biology. 345 (2): 315–24. doi:10.1016/j.jmb.2004.09.098. PMID   15571724.
  3. 1 2 3 4 5 Court DL, Oppenheim AB, Adhya SL (January 2007). "A new look at bacteriophage lambda genetic networks". Journal of Bacteriology. 189 (2): 298–304. doi:10.1128/JB.01215-06. PMC   1797383 . PMID   17085553.
  4. 1 2 3 4 5 Weiter JJ, Roh S (December 1992). "Viral infections of the choroid and retina". Infectious Disease Clinics of North America. 6 (4): 875–91. doi:10.1016/S0891-5520(20)30488-8. PMC   1460268 . PMID   9691025.
  5. ↑ Rattray A, Altuvia S, Mahajna G, Oppenheim AB, Gottesman M (July 1984). "Control of bacteriophage lambda CII activity by bacteriophage and host functions". Journal of Bacteriology. 159 (1): 238–42. doi:10.1128/JB.159.1.238-242.1984. PMC   215619 . PMID   6330032.
  6. 1 2 Ho Y, Lewis M, Rosenberg M (August 1982). "Purification and properties of a transcriptional activator. The cII protein of phage lambda". The Journal of Biological Chemistry. 257 (15): 9128–34. doi: 10.1016/S0021-9258(18)34252-2 . PMID   6212585.
  7. 1 2 3 4 5 6 7 Ho YS, Mahoney ME, Wulff DL, Rosenberg M (February 1988). "Identification of the DNA binding domain of the phage lambda cII transcriptional activator and the direct correlation of cII protein stability with its oligomeric forms". Genes & Development. 2 (2): 184–95. doi: 10.1101/gad.2.2.184 . ISSN   0890-9369. PMID   2966093.
  8. ↑ Kedzierska B, Glinkowska M, Iwanicki A, Obuchowski M, Sojka P, Thomas MS, Wegrzyn G (September 2003). "Toxicity of the bacteriophage lambda cII gene product to Escherichia coli arises from inhibition of host cell DNA replication". Virology. 313 (2): 622–8. doi: 10.1016/S0042-6822(03)00376-3 . PMID   12954227.
  9. 1 2 3 Kobiler O, Koby S, Teff D, Court D, Oppenheim AB (November 2002). "The phage lambda CII transcriptional activator carries a C-terminal domain signaling for rapid proteolysis". Proceedings of the National Academy of Sciences of the United States of America. 99 (23): 14964–9. Bibcode:2002PNAS...9914964K. doi: 10.1073/pnas.222172499 . PMC   137528 . PMID   12397182.
  10. ↑ Lorber A, Simon TM, Leeb J, Carroll PE (December 1975). "Chrysotherapy: pharmacological and clinical correlates". The Journal of Rheumatology. 2 (4): 401–10. doi:10.1093/genetics/140.3.875. PMC   1206672 . PMID   7672588.
  11. ↑ Chung S, Echols H (June 1977). "Positive regulation of integrative recombination by the cII and cIII genes of bacteriophage lambda". Virology. 79 (2): 312–9. doi:10.1016/0042-6822(77)90358-0. ISSN   0042-6822. PMID   867825.
  12. ↑ Dyson M, Suckling J (April 1978). "Stimulation of tissue repair by ultrasound: a survey of the mechanisms involved". Physiotherapy. 64 (4): 105–8. PMID   349580.
  13. ↑ Ho YS, Rosenberg M (September 1985). "Characterization of a third, cII-dependent, coordinately activated promoter on phage lambda involved in lysogenic development". The Journal of Biological Chemistry. 260 (21): 11838–44. doi: 10.1016/S0021-9258(17)39107-X . PMID   2931430.
  14. 1 2 3 Eichberg JW, McCullough B, Kalter SS, Thor DE, Rodriguez AR (1997). "Clinical, virological, and pathological features of herpesvirus SA8 infection in conventional and gnotobiotic infant baboons (Papio cynocephalus)". Archives of Virology. 50 (4): 255–70. doi:10.1128/jb.179.19.5987-5991.1997. PMC   179497 . PMID   9324241.
  15. ↑ Shotland Y, Koby S, Teff D, Mansur N, Oren DA, Tatematsu K, Tomoyasu T, Kessel M, Bukau B, Ogura T, Oppenheim AB (June 1997). "Proteolysis of the phage lambda CII regulatory protein by FtsH (HflB) of Escherichia coli". Molecular Microbiology. 24 (6): 1303–10. doi:10.1046/j.1365-2958.1997.4231796.x. PMID   9218777. S2CID   36740539.
  16. ↑ Krinke L, Wulff DL (December 1990). "RNase III-dependent hydrolysis of lambda cII-O gene mRNA mediated by lambda OOP antisense RNA". Genes & Development. 4 (12A): 2223–33. doi: 10.1101/gad.4.12a.2223 . ISSN   0890-9369. PMID   2148537.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.